Form D · Insurance
AMERICAN GENERAL LIFE INSURANCE CO
Houston, TX · CIK 0000005108
Offering snapshot reported Apr 8, 2026 · SEC filing
- Reported sold
- $589M Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $50M Reported outside-investor minimum
- First sale
- Nov 22, 2024 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$26,807,836 → $588,944,419
- Reported investors1 → 2
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 8, 2026 | Amendment | $588,944,419 | $562,136,583vs Apr 8, 2025 | 2 | SEC filing |
| Feb 20, 2026 | Amendment | $1,507,378,798 | $0vs Feb 20, 2025 | 45 | SEC filing |
| Feb 20, 2026 | Amendment | $328,017,537 | $0vs Feb 20, 2025 | 97 | SEC filing |
| Apr 8, 2025 | Amendment | $26,807,836 | No comparison | 1 | SEC filing |
| Feb 20, 2025 | Amendment | $1,507,378,798 | $0vs Feb 20, 2024 | 45 | SEC filing |
| Feb 20, 2025 | Amendment | $328,017,537 | $0vs Feb 20, 2024 | 97 | SEC filing |
| Apr 8, 2024 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Feb 20, 2024 | Amendment | $328,017,537 | $0vs Feb 17, 2023 | 97 | SEC filing |
| Feb 20, 2024 | Amendment | $1,507,378,798 | $0vs Feb 17, 2023 | 45 | SEC filing |
| Apr 6, 2023 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Feb 17, 2023 | Amendment | $328,017,537 | $0vs Feb 18, 2022 | 97 | SEC filing |
| Feb 17, 2023 | Amendment | $1,507,378,798 | $0vs Feb 18, 2022 | 45 | SEC filing |
| Apr 6, 2022 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 18, 2022 | Amendment | $1,507,378,798 | $0vs Feb 18, 2021 | 45 | SEC filing |
| Feb 18, 2022 | Amendment | $328,017,537 | $0vs Feb 18, 2021 | 97 | SEC filing |
| Feb 18, 2021 | Amendment | $328,017,537 | $0vs Feb 18, 2020 | 97 | SEC filing |
| Feb 18, 2021 | Amendment | $1,507,378,798 | $0vs Feb 18, 2020 | 45 | SEC filing |
| Feb 18, 2020 | Amendment | $1,507,378,798 | $0vs Feb 20, 2019 | 45 | SEC filing |
| Feb 18, 2020 | Amendment | $328,017,537 | $0vs Feb 20, 2019 | 97 | SEC filing |
| Feb 20, 2019 | Amendment | $1,507,378,798 | $0vs Feb 23, 2018 | 45 | SEC filing |
| Feb 20, 2019 | Amendment | $328,017,537 | $0vs Feb 23, 2018 | 97 | SEC filing |
| Feb 23, 2018 | Amendment | $328,017,537 | $2,375,000vs Feb 24, 2017 | 97 | SEC filing |
| Feb 23, 2018 | Amendment | $1,507,378,798 | $0vs Feb 24, 2017 | 45 | SEC filing |
| Feb 24, 2017 | Amendment | $1,507,378,798 | $0vs Feb 25, 2016 | 45 | SEC filing |
| Feb 24, 2017 | Amendment | $325,642,537 | $131,230vs Feb 25, 2016 | 96 | SEC filing |
| Feb 25, 2016 | Amendment | $1,507,378,798 | $0vs Feb 27, 2015 | 45 | SEC filing |
| Feb 25, 2016 | Amendment | $325,511,307 | $7,303,297vs Feb 27, 2015 | 96 | SEC filing |
| Feb 27, 2015 | Amendment | $1,507,378,798 | $0vs Feb 28, 2014 | 45 | SEC filing |
| Feb 27, 2015 | Amendment | $318,208,010 | $3,660,326vs Feb 28, 2014 | 96 | SEC filing |
| Oct 22, 2014 | Amendment | $20,000,000 | $0vs Oct 23, 2013 | 1 | SEC filing |
| Feb 28, 2014 | Amendment | $1,507,378,798 | $7,485,505vs Feb 28, 2013 | 45 | SEC filing |
| Feb 28, 2014 | Amendment | $363,096,651 | $57,645,437vs Feb 28, 2013 | 93 | SEC filing |
| Feb 28, 2014 | Amendment | $314,547,684 | $141,288,365vs Feb 28, 2013 | 95 | SEC filing |
| Oct 23, 2013 | Initial | $20,000,000 | No comparison | 1 | SEC filing |
| Feb 28, 2013 | Initial | $305,451,214 | No comparison | 74 | SEC filing |
| Feb 28, 2013 | Initial | $173,259,319 | No comparison | 68 | SEC filing |
| Feb 28, 2013 | Amendment | $1,499,893,293 | $4,086,803vs Feb 28, 2012 | 45 | SEC filing |
| Feb 28, 2012 | Amendment | $1,495,806,490 | $5,162,325vs Mar 2, 2011 | 47 | SEC filing |
| Mar 2, 2011 | Initial | $1,490,644,165 | No comparison | 45 | SEC filing |
| Mar 12, 2010 | Initial | $2,151,653 | No comparison | 25 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b, 3C, 3C.1, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $5.2M
- Finders' fees
- $0
- Form D file number
- 021-440600
AGL Institutional Life
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| J. Alden Associates, Inc. | None | J. Alden Associates, Inc. |
| Northwestern Mutual Investment Services, LLC | None | Northwestern Mutual Investment Services, LLC |
Source: Form D, filed Apr 8, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bruce R Abrams | Director |
| Katherine Ann Anderson | Director |
| David Robert Armstrong | Director, Executive |
| Gloria Ann Beissinger | Executive |
| Robert Michael Beuerlein | Director |
| James Bracken | Executive |
| John P Byrne | Executive |
| Steven D. Caldwell, Jr. | Executive |
| Jeffrey Howard Carlson | Director, Executive |
| Justin Jerome Wells Caulfield | Executive |
| Julie Ann Cotton Hearne | Executive |
| Elizabeth B. Cropper | Executive |
| Don Wayne Cummings | Director, Executive |
| Evelyn Curran | Executive |
| John B. Deremo | Executive |
| Thomas John Diemer | Director, Executive |
| David Ditillo | Director, Executive |
| John Q Doyle | Director |
| Jeffrey M Farber | Director |
| Terry Box Festervand | Executive |
| Terri N. Fiedler | Director |
| Christopher P. Filiaggi | Director |
| Christopher P. Filliaggi | Director |
| Mary Jane Bartolotta Fortin | Director, Executive |
| Deborah Ann Gero | Director |
| Emily W. Gingrich | Director |
| Jana Waring Greer | Director, Executive |
| Elias Farid Habayeb | Director, Executive |
| Ronald John Harris | Executive |
| Michael Philip Harwood | Director |
| Robert Frank Herbert, Jr. | Executive |
| Timothy Michael Heslin | Director, Executive |
| Kevin Timothy Hogan | Director, Executive |
| Kyle Lynn Jennings | Director |
| Lisa M Longino | Director, Executive |
| Stephen Arthur Maginn | Director |
| James A. Mallon | Director, Executive |
| Brian O. Moon | Executive |
| Christopher V Muchmore | Director, Executive |
| Christine A Nixon | Executive |
| Jonathan Joseph Novak | Director, Executive |
| David William O'leary | Director, Executive |
| Curtis Warren Olson | Director, Executive |
| Jeanette N. Pina | Executive |
| Jeannette N. Pina | Executive |
| Bryan Allan Pinsky | Director, Executive |
| Sabra R Purtill | Director, Executive |
| Sabyasachi Ray | Director, Executive |
| Rodney Eugene Rishel | Director, Executive |
| Craig Andrew Sabal | Director, Executive |
| Robert Jay Scheinerman | Executive |
| Robert Scott Schimek | Director, Executive |
| Charles Said Shamieh | Executive |
| Alan L Smith | Director, Executive |
| Christopher B. Smith | Director, Executive |
| Todd Paul Solash | Director, Executive |
| Eric G. Tarnow | Director |
| Alireza Vaseghi | Director |
| Adam Charles Winslow | Director, Executive |
| Jay Steven Wintrob | Director, Executive |
| William Carl Wolfe | Executive |
Issuer details
Industry: Insurance (See others in industry)
Address:
2727 A Allen Parkway
Houston, TX, 77019
Phone: 7135221111
Houston, TX, 77019
Phone: 7135221111